dedicated, in shape and ready to go. Twenty-six men and women from around the
world will head to Mt. Kilimanjaro, Africa on Sept. 13 to take another step
for the Prostate Cancer Climb.
The two-week expedition will
lead the 16-man, four-woman team to the “roof of Africa,” a 19,340-foot
volcano on the border between Tanzania and Kenya on behalf of prostate cancer
awareness. Mt. Kilimanjaro is the highest peak on the continent.
The goal of the Prostate
Cancer Climb is to raise $1 million for the Hap Weyman Memorial Prostate
Cancer Fund and its ongoing programs for research and education. Prostate
Cancer Research Institute is the fund administrator and the lead agency for
the Prostate Cancer Climb.
“Finding a cure for prostate
cancer is the ultimate goal,” said Glenn Weaver, PCRI Executive Director and
member of the climbing team, “but until that dream is realized we must
continue to help educate men and their families about prostate cancer
diagnosis, treatment and care.”
The Prostate Cancer Climb is
a groundbreaking effort established three years ago by Dr. Terry Weyman, a Los
Angeles chiropractor whose father, Hollywood television production manager Hap
Weyman, died of the of the disease in 1990. The climbers began their quest by
reaching the top of 22,840-foot Mt. Aconcagua, Argentina in 2001.
In order to make the journey
to Mt. Kilimanjaro, each climber is required to raise at least $2,000. By
supporting the climbers and the Hap Weyman Fund, all donors will be recognized
on the Climb Website and will have their names acknowledged in a flag salute
at the Uhuru Peak summit.
The climbers hail from South
Africa, Ireland, Canada and the United States.
At 75, Art Shafer is the oldest member of the Kilimanjaro team—and also a
prostate cancer survivor. A combination of hormone therapy and radiation
treatments have kept his disease in check, but Art worries that the high
“Kili” summit might be out of his reach. The tough Texan is still determined
“I am convinced that only the wings of an angel will put me on the summit, but
I will give it everything I’ve got,” said Shafer, who is proof that with
proper care and treatment, men who have been diagnosed can still lead happy
and productive lives.
“I definitely believe I owe my life to the research that has been done in the
past,” he said.
Robert Pugh, a survivor from Massachusettes, is looking forward to the
camaraderie of the climb. “The appeal of the climb is the fellowship with a
group of men who have also faced prostate cancer,” he said.
Pugh’s brother is a prostate cancer survivor and his father-in-law died from
the disease. “This is especially personal to me because now my son Bill faces
an exceptionally high risk group,” he said.
With an estimated 31,000
deaths in 2002, prostate cancer is the second leading cause of cancer death in
men. This year, more than 220,000 new cases are expected to be diagnosed.
The exciting events
surrounding the Aconcagua climb and the details concerning the Kilimanjaro
expedition can be viewed by visiting the Prostate Cancer Climb Website,